The Securities and Exchange Commission announced a complaint against the Chief Information Officer of pharmaceutical company Viatris for tipping his former colleague to nonpublic information about Mylan’s unannounced FDA drug approval, financial results, and an impending merger.
Antitrust approvals have been granted by the relevant governing authorities, including the Federal Trade Commission ("FTC"), with respect to the previously.